Health Matters for Women - Celebrating Women's Health Week!

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



May, 2023 


New from CDC Authors


Celebrating Women’s Health Week!

National Women’s Health Week starts each year on Mother’s Day. This health observance encourages women and girls to make their health a priority.


Cancer and Women

Most cancers take years to develop. Many things can affect your chance of getting cancer. You can take steps every day to lower your chance of getting certain kinds of cancer.


Emergency Department Visits Involving Mental Health Conditions, Suicide-Related Behaviors, and Drug Overdoses Among Adolescents — United States, January 2019–February 2023

High baseline rates of poor adolescent mental and behavioral health were exacerbated by the COVID-19 pandemic. This report shows by fall 2022, weekly emergency department visits among adolescents aged 12-17 years, and females in particular, for mental health conditions overall, suicide-related behaviors, and drug overdoses decreased compared with those during fall 2021; weekly ED visits among males were stable.


Surveillance for Violent Deaths — National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2020

This report summarizes data from CDC’s National Violent Death Reporting System (NVDRS) on violent deaths that occurred in 48 states, the District of Columbia, and Puerto Rico in 2020. The report found that intimate partner violence precipitated a large proportion of homicides for females. Mental health problems, intimate partner problems, interpersonal conflicts, and acute life stressors were primary circumstances for multiple types of violent death.


Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021

The Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy (MAT-LINK) is a surveillance network of seven clinical sites in the United States. Boston Medical Center, Kaiser Permanente Northwest, The Ohio State University, and the University of Utah were the initial clinical sites in 2019. In 2021, three clinical sites were added to the network (the University of New Mexico, the University of Rochester, and the University of South Florida) This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. 


Reproductive Health Counseling and Concerns Among Women with Congenital Heart Defects with and Without Disabilities

Women with disabilities are less likely to receive reproductive health counseling than women without disabilities. Yet, little is known about reproductive health counseling and concerns among women with congenital heart defects (CHD) and disabilities. This study used population-based survey data of women with CHD to examine contraceptive and pregnancy counseling and pregnancy concerns and experiences by disability status. 


Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination

This multisite, observational, matched cohort study of more than 80,000 pregnant people found that receipt of an mRNA monovalent coronavirus disease 2019 (COVID-19) booster vaccination in pregnancy was not associated with increased risk for thrombocytopenia, myocarditis, venous thromboembolism, ischemic stroke, or other serious adverse events within 21 or 42 days after booster vaccination.


Associations of Prenatal and Postnatal Exposure to Perfluoroalkyl Substances with Pubertal Development and Reproductive Hormones in Females and Males: The HOME Study

Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) may be associated with lower reproductive hormones and later puberty, but epidemiological studies evaluating these associations are scarce. This study examined associations of PFAS concentrations assessed from pregnancy to adolescence with pubertal development and reproductive hormones at age 12 years.


Associations Between Breastfeeding and Post-Perinatal Infant Deaths in the U.S.

Initiation of breastfeeding has been associated with reduced post-perinatal infant mortality. Although most states have initiatives to protect, promote, and support breastfeeding, no analysis of the association of breastfeeding and infant mortality has been conducted at the state and regional level. To understand the associations between breastfeeding and post-perinatal infant mortality, the initiation of breastfeeding with post-perinatal infant mortality was analyzed by geographic region and individual states within each region.

 


Snapshots: 

 

Woman choosing sanitary pads in the supermarket

Question of the Month:

The term “period poverty” can be described as inadequate access to menstrual hygiene products and education.


A. True

B. False


How did you do on April's question?

Over _______ of pregnancy-related deaths in the U.S. are preventable.


The answer is more than 80%! Most of you (64%) answered this question incorrectly last month and thought it was less than 50%. Sadly, many women die in the United States each year because of pregnancy or delivery complications. Over 80% of these deaths are preventable. Recognizing the urgent maternal warning signs, getting an accurate and timely diagnosis, and quality care can save lives. Learn more about urgent maternal warning signs!

 

National, State, Tribal, Local, and Territorial

Select Announcements, Statements, Reports, and Events from National, State, Tribal, Local, and Territorial Agencies and Organizations

Health Observances, June 2023


Scleroderma Awareness Month

National Congenital Cytomegalovirus Awareness Month


This service is provided by the CDC/ATSDR Office of Women's Health. Email comments or suggestions to owh@xxxxxxx.


For more information about women’s health, visit www.cdc.gov/women.


Disclaimer:

The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Links to non-Federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC/ATSDR or the Federal Government, and none should be inferred. The CDC/ATSDR is not responsible for the content of the individual organization Web pages found at these links.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux